New York 2025-2026 Regular Session

New York Assembly Bill A02352

Introduced
1/16/25  
Refer
1/16/25  

Caption

Requires insurers and health plans to grant automatic preauthorization approvals to eligible health care professionals in certain circumstances.

Summary

Bill A02352 aims to amend the insurance law and public health law in New York by establishing automatic preauthorization approvals for health care professionals under specific conditions. If an insurer has approved at least 90% of preauthorization requests from a health care professional within the last six months, that professional will automatically qualify for preauthorization for similar services without needing to submit a request. This automatic approval will remain effective until rescinded by the insurer, following a defined process that includes notification and the opportunity for appeal by the health care professional.

Impact

The bill will significantly alter the preauthorization landscape for health care services in New York. By mandating automatic approvals based on past approval rates, it aims to streamline the process for health care professionals and reduce administrative burdens. Insurers will need to adapt their evaluation processes and ensure compliance with the new requirements, which may lead to changes in how they manage preauthorization requests and claims payments.

Sentiment

The sentiment surrounding Bill A02352 appears to be generally supportive among health care professionals who see it as a means to reduce delays in patient care and administrative hurdles. However, there may be concerns from insurers regarding the potential increase in claims and the implications for their operational processes. The absence of recorded votes or committee discussions suggests that the bill may still be in the early stages of consideration.

Contention

Notable points of contention may arise from insurers who could argue that automatic approvals could lead to increased costs and potential misuse of services. Additionally, the criteria for rescinding approvals and the retrospective review process could be points of debate, particularly regarding how insurers can justify rescissions and the transparency of their decision-making processes.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.